Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talampanel in Advanced Parkinson's Disease with Dyskinesia
NCT00036296Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of talampanel in dyskinesia, sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2006; status: completed.
02
Drugs
talampanel
03
Conditions
dyskinesia
Beyond the preview
Go deeper on NCT00036296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036296.